These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3486441)

  • 1. Immune factors in narcolepsy.
    Langdon N; Lock C; Welsh K; Vergani D; Dorow R; Wachtel H; Palenschat D; Parkes JD
    Sleep; 1986; 9(1 Pt 2):143-8. PubMed ID: 3486441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HLA and narcolepsy. Apropos of 28 cases including 2 negative HLA-DR2].
    Confavreux C; Gebuhrer L; Betuel H; Freidel C; Bastuji H; Jouvet M; Aimard G; Devic M
    Rev Neurol (Paris); 1988; 144(5):327-31. PubMed ID: 3262232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of HLA-DR2, DQw1 negative post-traumatic narcolepsy].
    Maeda M; Tamaoka A; Hayashi A; Mizusawa H; Shoji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):811-3. PubMed ID: 8777810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR2 and narcolepsy.
    Billiard M; Seignalet J; Besset A; Cadilhac J
    Sleep; 1986; 9(1 Pt 2):149-52. PubMed ID: 3486442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence.
    Poirier G; Montplaisir J; Décary F; Momège D; Lebrun A
    Sleep; 1986; 9(1 Pt 2):153-8. PubMed ID: 3486443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA DR2 and DQ1 frequency among narcoleptic patients in Hong Kong Chinese.
    Wing YK; Chen CN; Ho CK
    Psychiatry Clin Neurosci; 1998 Oct; 52(5):523-7. PubMed ID: 10215015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy.
    Mignot E; Kimura A; Lattermann A; Lin X; Yasunaga S; Mueller-Eckhardt G; Rattazzi C; Lin L; Guilleminault C; Grumet FC; Mayer G; Dement WC; Underhill P
    Tissue Antigens; 1997 Apr; 49(4):329-41. PubMed ID: 9151385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurobiology of narcolepsy-cataplexy syndrome.
    Aldrich MS
    Int J Neurol; 1991-1992; 25-26():29-40. PubMed ID: 11980061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy.
    Honda Y; Juji T; Matsuki K; Naohara T; Satake M; Inoko H; Someya T; Harada S; Doi Y
    Sleep; 1986; 9(1 Pt 2):133-42. PubMed ID: 3010426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy.
    Black JL; Silber MH; Krahn LE; Avula RK; Walker DL; Pankratz VS; Fredrickson PA; Slocumb NL
    Biol Psychiatry; 2005 Sep; 58(6):504-9. PubMed ID: 16043129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage of human narcolepsy with HLA association to chromosome 4p13-q21.
    Nakayama J; Miura M; Honda M; Miki T; Honda Y; Arinami T
    Genomics; 2000 Apr; 65(1):84-6. PubMed ID: 10777671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.
    Matsuki K; Juji T; Tokunaga K; Naohara T; Satake M; Honda Y
    J Clin Invest; 1985 Dec; 76(6):2078-83. PubMed ID: 3865934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.
    Mignot E; Hayduk R; Black J; Grumet FC; Guilleminault C
    Sleep; 1997 Nov; 20(11):1012-20. PubMed ID: 9456467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wake disorders. I. Primary wake disorders].
    Billiard M; Carlander B
    Rev Neurol (Paris); 1998 Feb; 154(2):111-29. PubMed ID: 9773032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DQ beta chain DNA restriction fragments can differentiate between healthy and narcoleptic individuals with HLA-DR2.
    Inoko H; Ando A; Tsuji K; Matsuki K; Juji T; Honda Y
    Immunogenetics; 1986; 23(2):126-8. PubMed ID: 3007343
    [No Abstract]   [Full Text] [Related]  

  • 17. Narcolepsy and HLA in the Japanese.
    Juji T; Matsuki K; Tokunaga K; Naohara T; Honda Y
    Ann N Y Acad Sci; 1988; 540():106-14. PubMed ID: 2905117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II analysis in Jewish Israeli narcoleptic patients.
    Kwon OJ; Peled N; Miller K; Pillar G; Peled R; Lavie P; Brautbar C; Amar A
    Hum Immunol; 1995 Dec; 44(4):199-202. PubMed ID: 8770632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR2 and narcolepsy: not all narcoleptic-cataplectic patients are DR2.
    Guilleminault C; Grumet C
    Hum Immunol; 1986 Sep; 17(1):1-2. PubMed ID: 3488983
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte subsets in HLA-DR2-positive narcoleptic patients.
    Matsuki K; Honda Y; Naohara T; Satake M; Someya T; Harada S; Juji T
    Folia Psychiatr Neurol Jpn; 1985; 39(4):499-505. PubMed ID: 3879600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.